drugset / Trial / NCT05520892
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Phase 4
Recruiting
580 enrolled
Fujian Medical University Union Hospital
Longyan City First Hospital · collabNanping First Hospital Affiliated to Fujian Medical University · collabQuanzhou First Hospital · collabThe Affiliated Hospital Of Guizhou Medical University · collabThe Affiliated Hospital of Putian University · collabThe First Affiliated Hospital of Xiamen University · collabThe Second Hospital of Anhui Medical University · collabZhangzhou Affiliated Hospital of Fujian Medical University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to reduce related adverse reactions and economic burdens on the premise of ensuring the remission rate
Timeline
- Start
- 2022-10-06
- Primary completion
- 2025-08-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 0.4 g/kg | Intravenous |
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 1 g/kg | Intravenous |